ConductScience.org, home

Paper734052

The concept of drug dose for in vitro studies with chemotherapeutic agents.

Wheeler KT and 2 others. Radiat Res, 1978. Cited by 42 papers, by iCite.

Cite this record

ConductScience Library. The concept of drug dose for in vitro studies with chemotherapeutic agents. Papers, record 734052. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/734052

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The concept of drug dose for in vitro studies with chemotherapeutic agents.
PubMed
Journal
Radiat Res
PubMed
Year
1978
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
42
iCite
Relative citation ratio, by iCite
2.15
iCite
Revised in PubMed
2006-11-15
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wheeler KTK T
2Levin VAV A
3Deen DFD F

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Brain NeoplasmsMajor topic
Nitrosourea CompoundsMajor topic
Biological Transport
Cell Survival
Cells, Cultured
Dose-Response Relationship, Drug
Drug Stability
Half-Life
Time Factors

Source PubMed

Download CSV of topics

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.

PMIDTitleJournalYearIn PapersSource
24578726Combining microbubbles and ultrasound for drug delivery to brain tumors: current progress and overview.Theranostics2014https://conductscience.org/library/papers/24578726PubMed
9524098Unexpected in vitro chemosensitivity of malignant gliomas to 4-hydroxyperoxycyclophosphamide (4-HC).J Neurooncol1998https://conductscience.org/library/papers/9524098PubMed
8033302Growth kinetics of L1210 leukemic cells exposed to different concentration courses of methotrexate in vitro.Cancer Chemother Pharmacol1994https://conductscience.org/library/papers/8033302PubMed
7426313Dependence of the cytostatic effect of adriamycin on drug concenration and exposure time in vitro.Br J Cancer1980https://conductscience.org/library/papers/7426313PubMed
7318145Potentials and possible pitfalls of human stem cell analysis.Cancer Chemother Pharmacol1981https://conductscience.org/library/papers/7318145PubMed
6932940Is cell survival a determinant of the in situ response of 9L tumours?Br J Cancer Suppl1980https://conductscience.org/library/papers/6932940PubMed
6777821The combined action of chemical carcinogens on DNA repair in human cells.Radiat Environ Biophys1980https://conductscience.org/library/papers/6777821PubMed
6722006Misonidazole and CCNU: further evidence for a pharmacokinetic mechanism of chemosensitization and therapeutic gain.Br J Cancer1984https://conductscience.org/library/papers/6722006PubMed
6611843DNA repair kinetics in irradiated undifferentiated and terminally differentiated cells.Radiat Environ Biophys1983https://conductscience.org/library/papers/6611843PubMed
3971475Clinical pharmacokinetics of oral CCNU (lomustine).Cancer Chemother Pharmacol1985https://conductscience.org/library/papers/3971475PubMed
3948306Pharmacokinetics in experimental and clinical chemotherapy.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3948306PubMed
3882257Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. General considerations, the nitrosoureas and alkylating agents.Cancer Chemother Pharmacol1985https://conductscience.org/library/papers/3882257PubMed
3092427Intravesical chemotherapy: in vitro studies on the relationship between dose and cytotoxicity.Urol Res1986https://conductscience.org/library/papers/3092427PubMed
18335132-Nitroimidazole potentiation of nitrosourea induced cytotoxicity in subcutaneous implants of rat 9L brain tumor cells.J Neurooncol1991https://conductscience.org/library/papers/1833513PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/734052

GET https://conductscience.org/api/papers/v1/734052/authors